Evidence map›Paper›PMID 32457054›Full record

ArticleESMO open2020

Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration.

Carlo Palmieri, Daniel Palmer, Peter J M Openshaw, J Kenneth Baillie, Malcolm G Semple, Lance Turtle

Abstract readLetterComment
In one paragraph

Article in ESMO open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Carlo PalmieriDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK. Electronic address: C.Palmieri@liverpool.ac.uk.
Daniel PalmerDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
Peter J M OpenshawNational Heart and Lung Division, Faculty of Medicine, Imperial College, London, United Kingdom.
J Kenneth BaillieRoslin Institute, University of Edinburgh, Edinburgh, UK; Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
Malcolm G SempleAlder Hey Children's NHS Foundation Trust, Liverpool, UK; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.
Lance TurtleNIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Funding

Medical Research Council MC_PC_19025Medical Research Council MC_PC_19059
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsSevere acute respiratory syndrome-related coronavirusBetacoronavirusCoronavirus InfectionsCOVID-19HumansNew York CityPandemicsPneumonia, ViralPrognosisSARS-CoV-2cancerCOVID-19principles

Identifiers

PMID32457054
PMCPMC7252983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.